Charmacy Pharmaceutical Co., Ltd. (HKG:2289)

Hong Kong · Delayed Price · Currency is HKD

5.50

0.00 (0.00%)

At close: Oct 21, 2026

Charmacy Pharmaceutical Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	4,678	4,385	4,435	4,404	4,175	3,794
Revenue Growth	6.68%	-1.15%	0.72%	5.47%	10.06%	-4.96%
Gross Profit	334.52	336.01	320.88	288.38	268.61	234.12
Operating Income	125.74	131.54	135.31	108.28	93.49	74.42
Net Income	47.09	46.27	53.28	51.34	90.47	23.15
Earnings Per Share	0.44	0.43	0.49	0.48	0.84	0.21
EPS Growth	1.75%	-13.15%	3.79%	-43.25%	290.72%	-42.90%

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	541.08	764.65	573.86	644.76	503.81	641.76
Total Debt	1,442	1,837	1,409	1,375	1,186	1,327
Net Cash (Debt)	-900.82	-1,073	-835.6	-729.76	-681.72	-685.4
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-8.34	-9.93	-7.74	-6.76	-6.31	-6.35

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	321.49	270.89	106.04	-96.54	44.05	-19.54
Capital Expenditures	-6.05	-7.47	-15.73	-40.85	-8.59	-25.04
Free Cash Flow	315.44	263.42	90.31	-137.39	35.46	-44.58
Free Cash Flow Growth	19.75%	191.69%	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	7.15%	7.66%	7.23%	6.55%	6.43%	6.17%
Operating Margin	2.69%	3.00%	3.05%	2.46%	2.24%	1.96%
Pretax Margin	1.42%	1.47%	1.61%	1.53%	2.92%	0.87%
Profit Margin	1.01%	1.05%	1.20%	1.17%	2.17%	0.61%
FCF Margin	6.74%	6.01%	2.04%	-3.12%	0.85%	-1.18%

Dividends

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct '26 Oct 22, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Dividend Per Share	0.350	0.300	0.450	0.300	0.450
Dividend Per Share Growth	-29.74%	-33.33%	50.00%	-33.33%	-
Dividend Yield	6.37%	4.58%	4.89%	2.55%	7.38%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 22, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	10.92	15.29	18.67	24.75	7.28	21.21
Forward PE	-	13.45	13.45	13.45	13.45	13.45
P/FCF Ratio	1.63	2.69	11.01	-	18.56	-
PS Ratio	0.11	0.16	0.22	0.29	0.16	0.13